NASDAQ: AVIR
Atea Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Analyst price target for AVIR

Based on 1 analyst offering 12 month price targets for Atea Pharmaceuticals Inc

Min Forecast
$6.88+130.1%
Avg Forecast
$6.88+130.1%
Max Forecast
$6.88+130.1%

Should I buy or sell AVIR stock?

Based on 1 analyst offering ratings for Atea Pharmaceuticals Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Hold" rating. Learn More

Be the first to know when Wall Street analysts revise their AVIR stock forecasts and price targets.

AVIR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-08-13

1 of 1

Forecast return on equity

Is AVIR forecast to generate an efficient return?

Company
N/A
Industry
154.44%
Market
63.21%

Forecast return on assets

Is AVIR forecast to generate an efficient return on assets?

Company
N/A
Industry
22.34%

AVIR earnings per share forecast

What is AVIR's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$1.79
Avg 2 year Forecast
-$1.88

AVIR revenue forecast

What is AVIR's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$21.2M
Avg 2 year Forecast
$32.0M

AVIR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
AVIR$2.99$6.88+130.10%Hold
HRTX$1.66$4.00+140.96%Buy
ACIU$2.54$16.00+529.92%Buy
LXRX$0.70$4.00+475.54%Buy
VSTM$5.74$11.50+100.35%Strong Buy

Atea Pharmaceuticals Stock Forecast FAQ

Is Atea Pharmaceuticals Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: AVIR) stock is to Hold AVIR stock.

Out of 1 analyst, 0 (0%) are recommending AVIR as a Strong Buy, 0 (0%) are recommending AVIR as a Buy, 1 (100%) are recommending AVIR as a Hold, 0 (0%) are recommending AVIR as a Sell, and 0 (0%) are recommending AVIR as a Strong Sell.

If you're new to stock investing, here's how to buy Atea Pharmaceuticals stock.

What is AVIR's earnings growth forecast for 2025-2026?

(NASDAQ: AVIR) Atea Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 19.43%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 26.15%.

Atea Pharmaceuticals's earnings in 2025 is -$174,006,000.On average, 3 Wall Street analysts forecast AVIR's earnings for 2025 to be -$151,188,876, with the lowest AVIR earnings forecast at -$195,109,666, and the highest AVIR earnings forecast at -$119,937,544.

In 2026, AVIR is forecast to generate -$158,790,551 in earnings, with the lowest earnings forecast at -$207,779,125 and the highest earnings forecast at -$109,801,977.

What is AVIR's revenue growth forecast for 2025-2026?

(NASDAQ: AVIR) Atea Pharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 87.28%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.65%.

Atea Pharmaceuticals's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast AVIR's revenue for 2025 to be $1,793,910,910, with the lowest AVIR revenue forecast at $1,793,910,910, and the highest AVIR revenue forecast at $1,793,910,910.

In 2026, AVIR is forecast to generate $2,706,111,947 in revenue, with the lowest revenue forecast at $1,454,453,876 and the highest revenue forecast at $3,957,854,482.

What is AVIR's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: AVIR) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 22.34%.

What is AVIR's Price Target?

According to 1 Wall Street analyst that have issued a 1 year AVIR price target, the average AVIR price target is $6.88, with the highest AVIR stock price forecast at $6.88 and the lowest AVIR stock price forecast at $6.88.

The Wall Street analyst predicted that Atea Pharmaceuticals's share price could reach $6.88 by Aug 13, 2025. The average Atea Pharmaceuticals stock price prediction forecasts a potential upside of 130.1% from the current AVIR share price of $2.99.

What is AVIR's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: AVIR) Atea Pharmaceuticals's current Earnings Per Share (EPS) is -$2.07. On average, analysts forecast that AVIR's EPS will be -$1.79 for 2025, with the lowest EPS forecast at -$2.31, and the highest EPS forecast at -$1.42. In 2026, AVIR's EPS is forecast to hit -$1.88 (min: -$2.46, max: -$1.30).

What is AVIR's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: AVIR) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.